1353644-75-3

Upstream product

• 162012-69-3 7-fluoro-6-nitro-4-hydroxyquinazoline 
• 124-41-4 sodium methylate 
• 202197-31-7 1-(3-fluorobenzyl)-1H-indazol-5-ylamine 
• 162012-70-6 4-chloro-7-fluoro-6-nitroquinazoline 
• 1012057-47-4 7-methoxy-6-nitroquinazolin-4(3H)-one 
• 529508-58-5 1-(3-fluorobenzyl)-5-nitro-1H-carbazole 
• 55496-69-0 4-chloro-7-methoxy-6-nitroquinazoline 
• 162012-69-3 7-fluoro-6-nitro-3H-quinazolin-4-one 
• 446-32-2 4-fluoroanthranilic acid 
• 16499-57-3 7-fluoro-3H-quinazolin-4-one 
• 5401-94-5 5-nitroindazole 
• 456-41-7 1-(Bromomethyl)-3-fluorobenzene 

Downstream Products

• 897025-61-5 N⁴-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-7-methoxyquinazoline-4,6-diamine 
• 1353644-76-4 C₃₀H₂₃FN₆O₃ 
• 1353644-68-4 (3aR,6aR)-N-(4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3 ,4-b]pyrrole-5(1 H)-carboxamide 

Relevant academic research and scientific papers

AMINOQUINAZOLINE DERIVATIVES AND THEIR SALTS AND METHODS OF USE THEREOF

Provided herein are aminoquinazoline compounds, salts and uses thereof. The compounds have Formula (I), or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug ther

QUINAZOLINE COMPOUNDS

Provided are certain quinazoline compounds, compositions thereof and methods of use thereof. These quinazoline compound can effectively inhibit the overexpression and/or overactivity of epidermal growth factor receptor (EGFR).

QUINAZOLINE COMPOUNDS

Provided are certain quinazoline compounds, compositions thereof and methods of use thereof. These quinazoline compounds can effectively inhibit the overexpression and/or overactivity of epidermal growth factor receptor (EGFR).